v3.26.1
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated other Comprehensive Income (Loss)
Total
Balance at Dec. 31, 2024 $ 804 $ 67,279,033 $ (60,410,041) $ 9,063 $ 6,878,859
Balance (in Shares) at Dec. 31, 2024 8,042,747        
Common shares issued for exercise of warrants $ 375 5,624,625 5,625,000
Common shares issued for exercise of warrants (in Shares) 3,750,000        
Stock-based compensation 219,929 219,929
Common stock issued for cash, net $ 93 1,441,871 1,441,964
Common stock issued for cash, net (in Shares) 927,968        
Common stock issued for patent $ 45 850,455 850,500
Common stock issued for patent (in Shares) 450,000        
Cumulative translation adjustment (497) (497)
Net loss (3,475,836) (3,475,836)
Balance at Mar. 31, 2025 $ 1,317 75,415,913 (63,885,877) 8,566 11,539,919
Balance (in Shares) at Mar. 31, 2025 13,170,715        
Balance at Dec. 31, 2024 $ 804 67,279,033 (60,410,041) 9,063 6,878,859
Balance (in Shares) at Dec. 31, 2024 8,042,747        
Net loss         (5,675,312)
Balance at Jun. 30, 2025 $ 1,323 75,815,158 (66,085,353) 12,044 9,743,172
Balance (in Shares) at Jun. 30, 2025 13,234,027        
Balance at Mar. 31, 2025 $ 1,317 $ 75,415,913 $ (63,885,877) $ 8,566 $ 11,539,919
Balance (in Shares) at Mar. 31, 2025 13,170,715        
Common stock issued for cash, net $ 63,312        
Common stock issued for cash, net (in Shares) 6 66,095 66,101
Cumulative translation adjustment $ 3,478 $ 3,478
Net loss (2,199,476) (2,199,476)
Issuance of warrants for professional fees 333,150 333,150
Balance at Jun. 30, 2025 $ 1,323 75,815,158 (66,085,353) 12,044 9,743,172
Balance (in Shares) at Jun. 30, 2025 13,234,027        
Balance at Dec. 31, 2025 $ 1,551 79,017,730 (72,879,343) 10,831 6,150,769
Balance (in Shares) at Dec. 31, 2025 15,514,312        
Common stock issued for cash, net $ 76 701,408 701,484
Common stock issued for cash, net (in Shares) 756,187        
Cumulative translation adjustment 1,578 1,578
Net loss (2,692,465) (2,692,465)
Balance at Mar. 31, 2026 $ 1,627 79,719,138 (75,571,808) 12,409 4,161,366
Balance (in Shares) at Mar. 31, 2026 16,270,499        
Balance at Dec. 31, 2025 $ 1,551 79,017,730 (72,879,343) 10,831 6,150,769
Balance (in Shares) at Dec. 31, 2025 15,514,312        
Net loss         (6,527,116)
Balance at Jun. 30, 2026 $ 2,318 87,593,941 (79,406,459) 11,341 8,201,141
Balance (in Shares) at Jun. 30, 2026 23,184,634        
Balance at Mar. 31, 2026 $ 1,627 79,719,138 (75,571,808) 12,409 4,161,366
Balance (in Shares) at Mar. 31, 2026 16,270,499        
Stock-based compensation $ 625,485 $ 625,485
Common stock issued for cash, net $ 3,436,991        
Common stock issued for cash, net (in Shares) 343 5,145,236 5,145,579
Cumulative translation adjustment $ (1,068) $ (1,068)
Net loss (3,834,651) (3,834,651)
Common stock and warrants issued for cash, net $ 286 1,611,594 1,611,880
Common stock and warrants issued for cash, net (in Shares) 2,857,144        
Issuance of common stock for professional fees $ 62 492,488 492,550
Issuance of common stock for professional fees (in Shares) 620,000        
Balance at Jun. 30, 2026 $ 2,318 $ 87,593,941 $ (79,406,459) $ 11,341 $ 8,201,141
Balance (in Shares) at Jun. 30, 2026 23,184,634